The application of drug-eluting biodegradable magnesium alloy stent in treating esophageal benign stricture:current research status and prospect
10.3969/j.issn.1008-794X.2015.05.023
- VernacularTitle:食管良性狭窄药物镁合金可降解支架研究现状及展望
- Author:
Kai YANG
;
Yueqi ZHU
;
Yingsheng CHENG
- Publication Type:Journal Article
- Keywords:
esophageal stent;
biodegradability;
magnesium alloy;
benign esophageal stricture
- From:
Journal of Interventional Radiology
2015;(5):452-456
- CountryChina
- Language:Chinese
-
Abstract:
Stent implantation plays a more and more important role in the treatment of benign esophageal stenosis. Metal stents are most commonly used in the clinical practice, which can be classified into permanent stents and temporary retrieval stents. Permanent implantation of metal stents is easy to cause complications such as inflammatory hyperplasia, in-stent restenosis, perforation, bleeding, etc. Temporary retrieval stents should be removed with one week after it is implanted in order to avoid esophageal scar tissue repair and in-stent tissue hyperplasia, which can cause difficulty in its removing and produce higher recurrence rate of esophageal restenosis. Clinically, drug-eluting stents have already been used in cardiovascular system procedures, but at present the gastrointestinal drug-eluting stents are still in development and animal experiment stage. Biodegradable magnesium alloy stents have been widely employed in cardiovascular system procedures. With the rapid development of biological engineering materials, drug-eluting magnesium alloy stent has become a hot spot and the frontier in research field. This paper aims to make a comprehensive review about the current research status and prospect of the drug-eluting magnesium alloy stents, focusing on the stent technology, stent molding, coating modification, and the treatment of drug-eluting.
